Dafang Zhang1, Anish Potty, Parth Vyas, Joseph Lane. 1. *Harvard Medical School, Boston, MA; †Harvard-MIT Division of Health Sciences and Technology, Cambridge, MA; ‡Hospital for Special Surgery, New York, NY; and §Weill Cornell Medical College, New York, NY.
Abstract
OBJECTIVES: Human parathyroid hormone (PTH) is known to be efficacious in the treatment of osteoporosis and reduction of risk of vertebral and nonvertebral fractures; however, its role in the enhancement of human fracture healing is controversial. Our objective is to conduct a systematic literature review on the use of recombinant PTH in human fracture healing to (1) evaluate the evidence for recombinant PTH in human fracture healing and (2) assess whether there are notable differences between previous case reports and prospective trials. DATA SOURCES: We performed a literature search in PubMed, EMBASE, Web of Science, and the Cochrane Database of Systematic Reviews for "teriparatide," "PTH (1-84)," "fracture," and "healing." STUDY SELECTION: References of retrieved articles were screened for additional studies, and exclusion criteria were applied. DATA EXTRACTION: Due to the limited publications on the subject, case reports and case series were included in our data analysis. DATA SYNTHESIS: Due to the limited publications on the subject, our data are presented in simple tabular format. CONCLUSIONS: Our literature review yielded 16 publications on the use of recombinant PTH in human fracture healing and 2 randomized controlled trial with 1 retrospective subgroup analysis. There continues to be anecdotal evidence for the use of recombinant PTH to enhance fracture healing. There are discrepancies in study design in the randomized controlled trials and the majority of case reports and, additional prospective studies are warranted.
OBJECTIVES:Humanparathyroid hormone (PTH) is known to be efficacious in the treatment of osteoporosis and reduction of risk of vertebral and nonvertebral fractures; however, its role in the enhancement of humanfracture healing is controversial. Our objective is to conduct a systematic literature review on the use of recombinant PTH in humanfracture healing to (1) evaluate the evidence for recombinant PTH in humanfracture healing and (2) assess whether there are notable differences between previous case reports and prospective trials. DATA SOURCES: We performed a literature search in PubMed, EMBASE, Web of Science, and the Cochrane Database of Systematic Reviews for "teriparatide," "PTH (1-84)," "fracture," and "healing." STUDY SELECTION: References of retrieved articles were screened for additional studies, and exclusion criteria were applied. DATA EXTRACTION: Due to the limited publications on the subject, case reports and case series were included in our data analysis. DATA SYNTHESIS: Due to the limited publications on the subject, our data are presented in simple tabular format. CONCLUSIONS: Our literature review yielded 16 publications on the use of recombinant PTH in humanfracture healing and 2 randomized controlled trial with 1 retrospective subgroup analysis. There continues to be anecdotal evidence for the use of recombinant PTH to enhance fracture healing. There are discrepancies in study design in the randomized controlled trials and the majority of case reports and, additional prospective studies are warranted.
Authors: Per Aspenberg; Jorge Malouf; Umberto Tarantino; Pedro A García-Hernández; Costantino Corradini; Søren Overgaard; Jan J Stepan; Lars Borris; Eric Lespessailles; Frede Frihagen; Kyriakos Papavasiliou; Helmut Petto; José Ramón Caeiro; Fernando Marin Journal: J Bone Joint Surg Am Date: 2016-11-16 Impact factor: 5.284
Authors: Ivan Urits; Vwaire Orhurhu; Jessica Callan; Nishita V Maganty; Sara Pousti; Thomas Simopoulos; Cyrus Yazdi; Rachel J Kaye; Lauren K Eng; Alan D Kaye; Laxmaiah Manchikanti; Omar Viswanath Journal: Curr Pain Headache Rep Date: 2020-02-17
Authors: Mohit Bhandari; Ling Jin; Kyoungah See; Russel Burge; Nigel Gilchrist; Richard Witvrouw; Kelly D Krohn; Margaret R Warner; Qasim I Ahmad; Bruce Mitlak Journal: Clin Orthop Relat Res Date: 2016-03-01 Impact factor: 4.176